Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

6.09
+0.13002.18%
Pre-market: 6.100.0100+0.16%07:50 EDT
Volume:894.80K
Turnover:5.44M
Market Cap:347.43M
PE:-5.44
High:6.14
Open:6.03
Low:6.01
Close:5.96
52wk High:7.65
52wk Low:4.00
Shares:57.05M
Float Shares:36.92M
Volume Ratio:0.39
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):1.01
ROE:-43.13%
ROA:-24.55%
PB:2.71
PE(LYR):6.03

Loading ...

High Insider Ownership Growth Stocks To Watch In August 2026

Simply Wall St.
·
Aug 22

Abeona Therapeutics reports Q2 EPS (35c), consensus (25c)

TIPRANKS
·
Aug 17

Abeona Therapeutics is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 15

Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating

MT Newswires Live
·
Aug 14

Abeona Therapeutics, Inc. : Oppenheimer Cuts Target Price to $21 from $22

THOMSON REUTERS
·
Aug 14

CAMP4 Therapeutics Q2 Loss Per Share Misses Estimates on Non-Cash Derivative Charge

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Abeona Therapeutics Down Nearly 15%, on Pace for Largest Percent Decrease Since April 2024

Dow Jones
·
Aug 13

Abeona Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Abeona Shares Fall on Swing to 2Q Loss, Lower-than-Expected Revenue

Dow Jones
·
Aug 13

MeiraGTx Q2 Revenue Jumps on Reogen License Revenue

Reuters
·
Aug 13

Abeona Therapeutics Falls After Quarterly Loss, Revenue Miss

Reuters
·
Aug 13

Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations

Reuters
·
Aug 13

Abeona Therapeutics Q2 EPS $(0.35) Misses $(0.23) Estimate, Sales $11.380M Miss $12.239M Estimate

Benzinga Earnings
·
Aug 13

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

THOMSON REUTERS
·
Aug 13

Abeona Therapeutics Q2 EPS USD -0.35 VS. Ibes Estimate USD -0.23

THOMSON REUTERS
·
Aug 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Abeona Therapeutics Inc Expected to Post a Loss of 23 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Abeona’s New Phase 4 Wound Study: What ABEO Investors Should Watch

TIPRANKS
·
Aug 07

Abeona Therapeutics Schedules Conference Call on Q2 2026 Results

Reuters
·
Aug 06